BioCentury
ARTICLE | Company News

The Liposome, Wyeth-Ayerst International Inc. deal

April 15, 2013 7:00 AM UTC

The partners expanded their distribution agreement for LIPO's Abelcet liposomal amphotericin B. Wyeth-Ayerst will market the drug in Denmark as a first-line treatment of systemic Candida (fungal) inf...